Location History:
- Haifa, IL (2014)
- Herzlia, IL (2014)
- Pardes Chana-Karkur, IL (2014 - 2021)
Company Filing History:
8 out of 812 
4 out of 7 
1 out of 1 Years Active: 2014-2021
Title: The Innovative Contributions of Merav Bahat-Stromza
Introduction
Merav Bahat-Stromza is an accomplished inventor located in Pardes Chana-Karkur, Israel. With a total of eight patents to her name, she has made significant strides in the field of biomedical research, particularly in the area of central nervous system (CNS) diseases. Her innovative work showcases the potential of mesenchymal stem cells in therapeutic applications.
Latest Patents
Among her latest patents are groundbreaking discoveries concerning mesenchymal stem cells for the treatment of CNS diseases. One such patent discloses an isolated human cell that includes at least one mesenchymal stem cell phenotype and secretes brain-derived neurotrophic factor (BDNF). Notably, the basal secretion of BDNF in these cells is at least five times greater than that found in typical mesenchymal stem cells. Additionally, she has developed methods for generating these cells and outlined their uses in treating CNS diseases. Another significant patent provides isolated human cells and populations that comprise at least one astrocytic phenotype alongside at least one mesenchymal stem cell phenotype, where the mesenchymal stem cell phenotype is distinct from the astrocytic phenotype.
Career Highlights
Merav has had a notable career, having contributed her expertise to leading research institutions. Notably, she has been associated with Ramot at Tel Aviv University Ltd. and Brainstorm Cell Therapeutics Ltd. Her work at these organizations has allowed her to further explore the therapeutic applications of stem cells in neurodegenerative conditions, leading to advancements in medical science.
Collaborations
Throughout her career, Merav has collaborated with esteemed colleagues, including Eldad Melamed and Daniel Offen. These partnerships have bolstered her research efforts and have been essential in driving innovative projects that aim to improve treatment options for patients suffering from CNS diseases.
Conclusion
Merav Bahat-Stromza's contributions to the field of stem cell research and her commitment to developing therapies for CNS diseases exemplify the spirit of innovation. With her impressive portfolio of patents and collaborative endeavors, she continues to pave the way for advancements that could significantly enhance patient care and therapeutic outcomes.